alpha-aminopyridine has been researched along with nintedanib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Bruijn, P; Dingemans, AC; Koolen, SLW; Mathijssen, RHJ; Veerman, GDM | 1 |
1 other study(ies) available for alpha-aminopyridine and nintedanib
| Article | Year |
|---|---|
To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
Topics: Aminopyridines; Chromatography, High Pressure Liquid; Chromatography, Liquid; Humans; Indoles; Lactams; Lactams, Macrocyclic; Pyrazoles; Pyrimidines; Quinazolinones; Reproducibility of Results; Sulfones; Tandem Mass Spectrometry | 2021 |